ReleaseWire Connect

The pain therapeutics market covers the drugs used for the relief of acute and chronic pain. This market has long been characterized by high levels of generic revenue, derived largely from opioids, which see high levels of usage worldwide and particularly within the US.

DrugPipeline.net has announced the addition of “United States Adoptive Cell Therapy for Cancer Treatment Market Report 2017” research report to their website www.DrugPipeline.net

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2017, provides an overview of the Ornithine-Transcarbamylase Deficiency (Genetic Disorders) pipeline landscape.

Vaginal Cancer - Pipeline Review, H1 2017, provides an overview of the Vaginal Cancer (Oncology) pipeline landscape.

Western Equine Encephalitis - Pipeline Review, H1 2017, provides an overview of the Western Equine Encephalitis (Infectious Disease) pipeline landscape.

Zika virus Infections - Pipeline Review, H1 2017, provides an overview of the Zika virus Infections (Infectious Disease) pipeline landscape.

This report provides an overview of the pain pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Osteoarthritis Pain, Migraine pain and Neuropathic Pain, therefore covering a number of the most difficult-to-treat chronic and acute pain subtypes.

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth.

Asia-Pacific Pompe Disease Drugs Market Report 2017 report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Pompe Disease Drugs for these regions, from 2012 to 2022 (forecast).

DrugPipeline.net has announced the addition of “United States Antifungal Therapeutics Market Report 2017” research report to their website www.DrugPipeline.net.